Finance

Lists
ALA:ASX
Arovella Therapeutics Ltd
0,050 AUD
-1,96%
(-0,00100) 1D
20-окт., 16:00:00 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ALA...
Open
0,05 AUD
High
0,05 AUD
Low
0,05 AUD
Mkt. cap
61,65 млн
Avg. vol.
880,22 миң
Volume
16,20 миң
52-wk high
0,10 AUD
52-wk low
0,05 AUD
EPS
-0,01 AUD
Shares outstanding
1,21 млд
No. of employees
14
Open
0,05 AUD
High
0,05 AUD
Low
0,05 AUD
Mkt. cap
61,65 млн
Avg. vol.
880,22 миң
Volume
16,20 миң
52-wk high
0,10 AUD
52-wk low
0,05 AUD
EPS
-0,01 AUD
Shares outstanding
1,21 млд
No. of employees
14
News stories
From web sources and news partners
About Arovella Therapeutics Ltd
CEOMichael Baker
Employees14
Founded1999
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
1,60 млн
1,60 млн
144,61 миң
144,61 миң
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,37 млн
1,37 млн
1,57 млн
1,57 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
721,91 миң
721,91 миң
670,81 миң
670,81 миң
Operating expense
2,75 млн
2,75 млн
2,86 млн
2,86 млн
Total operating expenses
2,75 млн
2,75 млн
2,86 млн
2,86 млн
Operating income
-1,15 млн
-1,15 млн
-2,71 млн
-2,71 млн
Other non operating income
-
-
-
-
EBT including unusual items
-939,35 миң
-939,35 миң
-2,52 млн
-2,52 млн
EBT excluding unusual items
-939,35 миң
-939,35 миң
-2,52 млн
-2,52 млн
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
449,58 миң
449,58 миң
528,34 миң
528,34 миң
Net income
-939,35 миң
-939,35 миң
-2,52 млн
-2,52 млн
Net profit margin
-58,55%
-58,55%
-1 741,81%
-1 741,81%
Earnings per share
-
-
-
-
Interest and investment income
207,81 миң
207,81 миң
192,21 миң
192,21 миң
Interest expense
-
-
-
-
Net interest expenses
207,81 миң
207,81 миң
192,21 миң
192,21 миң
Depreciation and amortization charges
29,58 миң
29,58 миң
29,28 миң
29,28 миң
EBITDA
-1,12 млн
-1,12 млн
-2,68 млн
-2,68 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору